Cited 0 times in
Impact of mutation status on efficacy outcomes in TOPAZ-1: A phase III study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in advanced biliary tract cancer (BTC)
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-06-02T00:58:41Z | - |
dc.date.available | 2023-06-02T00:58:41Z | - |
dc.date.issued | 2022-11 | - |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194556 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Oxford University Press | - |
dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Impact of mutation status on efficacy outcomes in TOPAZ-1: A phase III study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in advanced biliary tract cancer (BTC) | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | J.W. Valle | - |
dc.contributor.googleauthor | S. Qin | - |
dc.contributor.googleauthor | L. Antonuzzo | - |
dc.contributor.googleauthor | D. Tougeron | - |
dc.contributor.googleauthor | C-K. Lee | - |
dc.contributor.googleauthor | B.J. Tan | - |
dc.contributor.googleauthor | M. Ikeda | - |
dc.contributor.googleauthor | V. Guthrie | - |
dc.contributor.googleauthor | P. McCoon | - |
dc.contributor.googleauthor | Y.S. Lee | - |
dc.contributor.googleauthor | N. Rokutanda | - |
dc.contributor.googleauthor | M. Żotkiewicz | - |
dc.contributor.googleauthor | G. Cohen | - |
dc.contributor.googleauthor | D-Y. Oh | - |
dc.identifier.doi | 10.1016/j.annonc.2022.10.104 | - |
dc.relation.journalcode | J00171 | - |
dc.identifier.eissn | 1569-8041 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0923753422042958 | - |
dc.citation.volume | 33 | - |
dc.citation.number | Suppl 9 | - |
dc.citation.startPage | S1457 | - |
dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, Vol.33(Suppl 9) : S1457, 2022-11 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.